Newswire (Published: Friday, September 6, 2019, Received: Friday, September 6, 2019, 3:25:38 PM CDT)
Word Count: 557
2019 SEP 06 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Daily -- A new study on Oncology - Prostate Cancer is now available. According to news reporting out of Seattle, United States, by NewsRx editors, research stated, “The prostate biopsy pathology report represents a critical document used for decision-making in patients diagnosed with prostate cancer, yet the content exceeds the health literacy of most patients. We sought to create and compare the effectiveness of a patient-centered prostate biopsy report compared with standard reports.”
Financial support for this research came from Pacific Northwest Prostate Cancer SPORE.
Our news journalists obtained a quote from the research from the University of Washington, “Using a modified Delphi approach, prostate cancer experts identified critical components of a prostate biopsy report. Patient focus groups provided input for syntax and formatting of patient-centered pathology reports. Ninety-four patients with recent prostate biopsies were block randomized to the standard report with or without the patient-centered report. We evaluated patient activation, self-efficacy, provider communication skills, and prostate cancer knowledge. Experts selected primary and secondary Gleason score and the number of positive scores as the most important elements of the report. Patients prioritized a narrative design, non-threatening language and information on risk classification. Initial assessments were completed by 87% (40/46) in the standard report group and 81% (39/48) in the patient-centered report group. There were no differences in patient activation, self-efficacy, or provider communication skills between groups. Patients who received the patient-centered report had significantly improved ability to recall their Gleason score (100% vs. 85%, p=0.026) and number of positive cores (90% vs. 65%, p=0.014). In total, 86% of patients who received the patient-centered report felt that it helped them better understand their results and should always be provided. Patient-centered pathology reports are associated with significantly higher knowledge about a prostate cancer diagnosis.”
According to the news editors, the research concluded: “These important health information documents may improve patient-provider communication and help facilitate shared decision-making among patients diagnosed with prostate cancer.”
For more information on this research see: The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized study. Prostate Cancer and Prostatic Diseases, 2019;():. Prostate Cancer and Prostatic Diseases can be contacted at: Nature Publishing Group, 345 Park Avenue South, New York, NY 10010-1707, USA. (Nature Publishing Group - http://www.nature.com/; Prostate Cancer and Prostatic Diseases - http://www.nature.com/pcan/)
Our news journalists report that additional information may be obtained by contacting J.L. Gore, Dept. of Urology, University of Washington, Seattle, WA, United States. Additional authors for this research include N. Scalzo, A. Chu, B. Shiff, J.T. Kearns, G.W. Dy, L.C. Macleod, M. Mossanen, W.J. Ellis, D.W. Lin, J.L. Wright, L.D. True and J.L Gore.
The direct object identifier (DOI) for that additional information is: https://doi.org/10.1038/s41391-019-0169-7. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.
Publisher contact information for the journal Prostate Cancer and Prostatic Diseases is: Nature Publishing Group, 345 Park Avenue South, New York, NY 10010-1707, USA.
(Our reports deliver fact-based news of research and discoveries from around the world.)
University of Washington
New York City
Science and Technology
Health and Wellness
Medical Conditions and Diseases
Men's Health Issues
Medical Specialties and Practices